Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better reassurances to customers

"There are only a handful of people in the world who have experience in running a direct-to-consumer genetic testing company — and I am one of them," Anne Wojcicki said.